HOME >> BIOLOGY >> NEWS
Shark attack worries? Driving to the beach is more deadly

, boating and diving accidents.

He says when most attacks occur, they happen in 3 to 4 feet of water. "But often, that can mean you're several hundred feet away from the beach," he notes. "Also, most attacks occur in water that is murky and not very clear.

"A greater percentage of beachgoers are injured by jellyfish, stingrays or hardhead and gafftop fishes, which have poisonous spines. They are more likely to cause harm than a shark."

He says when shark attacks occur, often they are accidental.

"Humans are not a shark's preferred food choice," he says.

"They don't regard the human shape as a prey item. Sometimes you hear reports of surfers having their boards hit by a shark, and it's probably because the board resembles the shape of a seal, which is a prime food source for sharks."

McEachran says some common sense can go a long way in avoiding contact with sharks.

"Sharks generally don't like to be around people," he adds.

"Most people are safe at the beach. To put your mind at ease, go to a beach that has lifeguards. They should be looking for possible sharks.

"Shark attacks are like airplane crashes," he notes. "The vast majority of airplane trips are safe, but when a crash occurs, it gets big headlines. If you use some good common sense in the water, you should be fine."


'"/>

Contact: Keith Randall
kr@univrel.tamu.edu
979-845-4644
Texas A&M University
29-Jun-2005


Page: 1 2

Related biology news :

1. Shark skin saves naval industry money
2. Shark cartilage cancer cure shows danger of pseudoscience
3. High-intensity ultrasound may launch attack on cancer, wherever it lurks
4. Using stem cells to help heart attack victims
5. System to analyze beating heart stem cells could lead to heart attack treatments
6. Cardiac patches stimulate regeneration, improve function after heart attack
7. Potent possibilities for parasite attack
8. Combining molecular imaging technologies to stop/prevent heart attacks
9. $5M gift will attack Lou Gehrigs disease from all angles
10. Common genetic variation is linked to substantial risk for heart attack
11. Alien plants attack using resource conservation as weapon, researchers say

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Shark attack worries Driving the beach more deadly

(Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, a ... Internet of Things (IoT), today announced the appointment of ... operating officer. Previously a strategic advisor to the firm, ... operations. Mr. Traynor is based out of the C-Labs ... reports to Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... -- The Secure Identity & Biometrics Association (SIBA) and ... formation of The Airport Entry and Exit Working ... Biometric Entry and Exit Solutions Framework for Airports ... BORDERPOL, the international non-profit organization that works directly ... border security, traveler and migration systems. ...
(Date:11/18/2014)... 2014 The Parenteral Drug Association (PDA) today confirmed ... speak and at least seven more will participate in the ... Shoreham Hotel in Washington D.C. , Dec. ... significant support from the regulatory agencies in the ... in our effort to help advance the use of metrics ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
(Date:12/17/2014)... CA (PRWEB) December 17, 2014 ... today that it has entered into a technology ... Company (ADM) to apply DNA2.0’s proprietary protein engineering ... engineering process. , “We are extremely excited that ... engineering platform. This proprietary bioengineering technology has ...
(Date:12/17/2014)... 17, 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a primary commercial focus on China ... a Type C meeting with the U.S. Food and ... held in February 2015.  During this meeting the Company ...
(Date:12/15/2014)... PETACH TIKVAH, Israel , Dec. 15, ... BCLI ), a leading developer of adult stem cell ... Brainstorm Cell Therapeutics Ltd. was awarded a grant of ... Office of the Chief Scientist (OCS).  This is the ... grant support from the Office of the Chief Scientist, ...
(Date:12/15/2014)... , Dec. 15, 2014  Ascendis Pharma ... TransCon technology to address significant unmet medical needs, ... ongoing Phase 2 pediatric study to evaluate once-weekly ... deficiency, or GHD.  This interim analysis consists of ... total enrollment in the study, completing all six ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4
Cached News: